| Literature DB >> 19108925 |
S Chearskul1, W Kriengsinyos, S Kooptiwut, S Sangurai, S Onreabroi, M Churintaraphan, N Semprasert, W Nitiyanant.
Abstract
Effects of glucomannan as a supplementary treatment in type 2 diabetes mellitus were investigated by measuring ghrelin, leptin and insulin responses to OGTT. Glucomannan enhanced prandial ghrelin reduction when given before glucose load and impeded the rise of fasting ghrelin after 4-week supplement. Ghrelin-induced feeding may be attenuated by glucomannan.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19108925 DOI: 10.1016/j.diabres.2008.11.014
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN: 0168-8227 Impact factor: 5.602